CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Scisparc Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Scisparc Ltd
20 Raul Wallenberg Street, Tower A
Phone: +972 36103100p:+972 36103100 TEL AVIV-YAFO, 6971916  Israel Fax: +972 36167056f:+972 36167056
Business Summary
Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
5912 Drug stores and proprietary stores
5999 Miscellaneous retail stores, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ItschakShrem 74 8/21/2020 8/21/2020
Chief Executive Officer, Director AmitayWeiss 62 8/21/2020 8/21/2020
Chief Financial Officer OzAdler 38 4/24/2018 3/1/2017
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Brain Bright Ltd.
Evero Health Ltd.
Nasvax Ltd.
6 additional Business Names available in full report.

General Information
Number of Employees: 3 (As of 12/31/2023)
Outstanding Shares: 2,586,686 (As of 3/28/2024)
Shareholders: 22
Stock Exchange: NASD
Fax Number: +972 36167056


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024